Advertisement
News
Advertisement

Thermo Fisher licenses sepsis test to Japanese firm

Tue, 11/20/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Thermo Fisher Scientific Inc.(NYSE: TMO) has signed a long-term license agreement with Japanese firm Fujirebio Inc. to make its test for the early detection of sepsis available on the Japanese firms laboratory instruments. Fujirebio’s Lumipulse product line of lab instruments is used in a significant number of hospitals and clinical reference labs in Japan and will be extended with future placements of Lumipulse platforms in other markets worldwide.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading